Non–Small Cell Lung Cancer: Other Actionable Mutations
2 vistas
• 07/04/23
0
0
Empotrar
administrator
Suscriptores
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios